Meropenem Trihydrate: Scientific Dossier for Resistance and Infection Research

Executive Summary: Meropenem trihydrate is a broad-spectrum carbapenem β-lactam antibiotic effective against both gram-negative and gram-positive bacteria, exhibiting low MIC90 values in standardized assays (APExBIO). It acts by inhibiting bacterial cell wall synthesis via high-affinity binding to penicillin-binding proteins, resulting in rapid cell lysis and death (Mechanistic Insights). Its stability against β-lactamases and compatibility with metabolomics workflows have advanced the study of resistance phenotypes, as recently demonstrated by LC-MS/MS metabolomics (Dixon et al., 2025). The compound is highly soluble in water and DMSO, but insoluble in ethanol, and is recommended for short-term solution use at -20°C. In vivo, meropenem trihydrate has proven efficacy in reducing infection and tissue damage in acute necrotizing pancreatitis models (Benchmarks & Translation).

Biological Rationale

Carbapenem antibiotics, such as Meropenem trihydrate, are regarded as last-resort agents in the treatment of multi-drug resistant bacterial infections (Dixon et al., 2025). The rise of extended-spectrum β-lactamase (ESBL)-producing and carbapenemase-producing Enterobacterales (CPE) has placed new demands on the sensitivity, specificity, and stability of antibiotic agents for both clinical and research settings. Meropenem trihydrate provides a robust, reproducible benchmark for evaluating resistance mechanisms and developing diagnostic tools (Resistance Mechanisms). Its broad-spectrum activity includes efficacy against Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., Citrobacter spp., and Streptococcus pneumoniae at low MIC90 values (typically ≤0.25–0.5 μg/mL, pH 7.5). The antibiotic is also suitable for translational models, such as acute necrotizing pancreatitis, where it reduces bacterial burden and tissue injury (Benchmarks & Translation).

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate targets the synthesis of the bacterial cell wall by binding to multiple penicillin-binding proteins (PBPs), including PBP2 and PBP3 (Mechanistic Insights). This binding inhibits transpeptidation and cross-linking of peptidoglycan, leading to rapid osmotic cell lysis and bacterial death. The compound is highly resistant to hydrolysis by most β-lactamases, including ESBLs, due to its carbapenem core structure. Its activity is pH-dependent, with optimal antibacterial effects at physiological pH (7.5) and reduced activity under acidic conditions (pH 5.5). Meropenem trihydrate's trihydrate form enhances solubility and stability in aqueous buffers, supporting its use in metabolomics and resistance profiling workflows (Translational Research).

Evidence & Benchmarks

• Meropenem trihydrate displays low MIC90 values (≤0.5 μg/mL at pH 7.5) against E. coli, K. pneumoniae, and Streptococcus pneumoniae in standardized broth microdilution assays (APExBIO).
• LC-MS/MS metabolomics differentiates carbapenemase-producing Enterobacterales (CPE) from non-CPE isolates using metabolic biomarkers after 6 hours of antibiotic-free growth, supporting Meropenem trihydrate's role in resistance phenotype discovery (Dixon et al., 2025).
• Meropenem trihydrate retains antibacterial activity in the presence of most β-lactamase enzymes, but is inactivated by class A, B, and D carbapenemases, highlighting the need for resistance surveillance (Mechanistic Insights).
• In vivo rat models of acute necrotizing pancreatitis show reduced pancreatic infection, hemorrhage, and fat necrosis after Meropenem trihydrate administration at 30 mg/kg, especially when combined with adjunctive agents like deferoxamine (Benchmarks & Translation).
• Meropenem trihydrate is soluble in water (≥20.7 mg/mL at 25°C with warming) and DMSO (≥49.2 mg/mL); it is insoluble in ethanol, supporting compatibility with diverse in vitro and metabolomics assays (APExBIO).

This article advances prior reviews by directly correlating Meropenem trihydrate's mechanistic and solubility properties to recent metabolomics-driven resistance profiling (Mechanistic Insights & Metabolomic), extending the experimental framework provided in Carbapenem Antibiotic in Resistance and providing new evidence for translational application as discussed in Translational Research: Mechanist.

Applications, Limits & Misconceptions

Meropenem trihydrate is widely employed in antibacterial susceptibility testing, resistance profiling, and translational infection models. It is a preferred standard for benchmarking resistance in Enterobacterales due to its broad activity and β-lactamase stability. In metabolomics, Meropenem trihydrate supports rapid, machine-learning-driven identification of resistant phenotypes by enabling untargeted metabolic profiling in the presence or absence of the antibiotic. Its high water and DMSO solubility simplify preparation for high-throughput applications.

Common Pitfalls or Misconceptions

• Meropenem trihydrate is not effective against strains producing high-activity carbapenemases (e.g., KPC, NDM, OXA-48); resistance must be verified by molecular or metabolomics assays (Dixon et al., 2025).
• The compound is not indicated for clinical or diagnostic use in humans; it is strictly for scientific research applications (APExBIO).
• Stability is reduced at room temperature or in solution for >24 hours; fresh solutions or -20°C storage are required for reproducible results (APExBIO).
• Solubility is limited in nonpolar solvents, including ethanol; attempts to prepare solutions in such media will fail.
• Performance in biofilm or slow-growing cultures may differ from planktonic susceptibility results and requires tailored protocols.

Workflow Integration & Parameters

Meropenem trihydrate (SKU B1217) from APExBIO is supplied as a solid, intended for reconstitution in sterile water (≥20.7 mg/mL at 25°C with gentle warming) or DMSO (≥49.2 mg/mL). For susceptibility assays, prepare fresh solutions and use within 24 hours, or aliquot and store at -20°C. For metabolomics workflows, its high solubility enables direct addition to culture media for time-course resistance profiling or metabolic fingerprinting. The compound is compatible with LC-MS/MS, supporting both endometabolome and exometabolome analyses (Dixon et al., 2025). For infection models, validated dosing parameters (e.g., 30 mg/kg in rat studies) can guide translational research while ensuring species-specific pharmacokinetics are controlled. Refer to the official Meropenem trihydrate product page for comprehensive preparation and handling instructions.

Conclusion & Outlook

Meropenem trihydrate remains a cornerstone for research on bacterial resistance, cell wall inhibition, and translational infection models. Its reproducible low MIC90, robust β-lactamase stability, and proven compatibility with advanced metabolomics and susceptibility workflows enable high-confidence experimental design. As resistance mechanisms evolve, Meropenem trihydrate—especially as supplied by APExBIO—offers a validated standard for integrating phenotypic, molecular, and metabolic data in antimicrobial research. Ongoing advances in metabolomics and machine learning are poised to further enhance its utility in resistance detection and therapeutic development (Dixon et al., 2025).